CN104940712A - Traditional Chinese medicine preparation for treating arteriosclerosis - Google Patents
Traditional Chinese medicine preparation for treating arteriosclerosis Download PDFInfo
- Publication number
- CN104940712A CN104940712A CN201510455175.6A CN201510455175A CN104940712A CN 104940712 A CN104940712 A CN 104940712A CN 201510455175 A CN201510455175 A CN 201510455175A CN 104940712 A CN104940712 A CN 104940712A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine preparation
- crude drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine preparation for treating arteriosclerosis. The traditional Chinese medicine preparation for treating arteriosclerosis comprises the following crude drugs in parts by weight: 19 to 21 parts of tall gastrodis tuber, 19 to 21 parts of fleece-flower roots, 19 to 21 parts of radix salviae miltiorrhizae, 11 to 13 parts of bamboo leaves, 11 to 13 parts of astragalus membranaceus, 11 to 13 parts of ephedra, 8 to 10 parts of semen cuscutae, 8 to 10 parts of ginseng, 8 to 10 parts of cortex lycii radicis, 8 to 10 parts of garden balsam stems, 8 to 10 parts of notopterygium roots, 8 to 10 parts of liquorice, 4 to 6 parts of poria cocos, 4 to 6 parts of fructus ligustri lucidi, 4 to 6 parts of tortoise shells, 4 to 6 parts of mint, 4 to 6 parts of cassia twig, 4 to 6 parts of lumbricus, 4 to 6 parts of fructus liquidambaris and 4 to 6 parts of achyranthes bidentata. The traditional Chinese medicine preparation provided by the invention has the advantages of obvious curative effect, low probability of relapse, and zero toxic or side effects.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to one and treat arteriosclerotic Chinese medicine preparation.
Background technology
Arteriosclerosis is a kind of non-inflammation pathological changes of tremulous pulse, ductus arteriosus wall can be made to thicken, hardening, follows the string, luminal stenosis.Arteriosclerosis be with age and occur angiopathy, its rule normally adolescence occur, increase the weight of period to person in middle and old age, fall ill.Male is many compared with women, and primary disease increases gradually in China in recent years, becomes one of old people's main cause of death.The cause of disease: cause in the arteriosclerotic cause of disease and the most important thing is hypertension, hyperlipemia, smoking.Other such as obesity, diabetes, hypomotility, tense situation, advanced age, family's medical histories, short-tempered etc. all arteriosclerosis can be caused.Clinical manifestation: early stage arteriosclerotic, Most patients nearly all without any clinical symptoms, development of hiding under being all in concealment state; Mid-term arteriosclerotic, the clinical symptoms such as Most patients all more or less listless and aching, the limping of had palpitation, chest pain, uncomfortable in chest, headache, dizziness, the cool fiber crops of extremity, extremity, vision reduction, hypomnesis, insomnia and dreamful sleep, different patients has different symptoms.
At present, treat arteriosclerotic medicine and there is slow, the easily recurrence of taking effect, deficiency that side effect is larger, it is very necessary that therefore invention one treats arteriosclerotic medicine safely and effectively.
Summary of the invention
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides one and treating arteriosclerotic Chinese medicine preparation.
One treats arteriosclerotic Chinese medicine preparation, is made up of the crude drug of following weight portion: Rhizoma Gastrodiae 19-21 part, Radix Polygoni Multiflori 19-21 part, Radix Salviae Miltiorrhizae 19-21 part, Folium Bambusae 11-13 part, Radix Astragali 11-13 part, Herba Ephedrae 11-13 part, Semen Cuscutae 8-10 part, Radix Ginseng 8-10 part, Cortex Lycii 8-10 part, Herba speranskiae tuberculatae 8-10 part, Rhizoma Et Radix Notopterygii 8-10 part, Radix Glycyrrhizae 8-10 part, Poria 4-6 part, Fructus Ligustri Lucidi 4-6 part, Carapax Et Plastrum Testudinis 4-6 part, Herba Menthae 4-6 part, Ramulus Cinnamomi 4-6 part, Pheretima 4-6 part, Fructus Liquidambaris 4-6 part, Radix Achyranthis Bidentatae 4-6 part.
The arteriosclerotic Chinese medicine preparation of described treatment, is made up of the crude drug of following weight portion: 20 parts, Rhizoma Gastrodiae, Radix Polygoni Multiflori 20 parts, Radix Salviae Miltiorrhizae 20 parts, 12 parts, Folium Bambusae, the Radix Astragali 12 parts, 12 parts, Herba Ephedrae, Semen Cuscutae 9 parts, Radix Ginseng 9 parts, Cortex Lycii 9 parts, Herba speranskiae tuberculatae 9 parts, Rhizoma Et Radix Notopterygii 9 parts, 9 parts, Radix Glycyrrhizae, 5 parts, Poria, Fructus Ligustri Lucidi 5 parts, Carapax Et Plastrum Testudinis 5 parts, Herba Menthae 5 parts, Ramulus Cinnamomi 5 parts, Pheretima 5 parts, Fructus Liquidambaris 5 parts, Radix Achyranthis Bidentatae 5 parts.
The preparation method of the arteriosclerotic Chinese medicine preparation of described treatment, takes each crude drug according to described parts by weight, packs after each crude drug mixing taken, sterilization.
Usage and consumption: the Chinese medicine preparation made is added suitable quantity of water and decoct, be heated to boiling point, decoct 30-50 minute, filter to obtain medicinal liquid, decoct three times continuously by the method, decoct gained medicinal liquid by three times and merge, be equally divided into three parts, patient every day is early, middle and late respectively takes portion; It within 10 days, is a course for the treatment of.
The Chinese medicine preparation of the present invention made by above-mentioned each crude drug and proportioning thereof, has the effect of expelling wind and activating blood circulation, blood-activating analgetic, nourishing the liver and kidney, thus reaches the arteriosclerotic object for the treatment of.
The beneficial effect that the present invention is compared with prior art had is: the present invention has advantage that is evident in efficacy, that not easily recur, have no side effect.
Below in conjunction with clinical experiment, beneficial effect of the present invention is described:
(1) clinical data: the present invention treat altogether arteriosclerotic 70 example, wherein man 41 example, female 29 example, the age be 43-68 year.
(2) Therapeutic Method: the Chinese medicine preparation made is added suitable quantity of water and decoct, be heated to boiling point, decoct 30-50 minute, filter to obtain medicinal liquid, decoct three times continuously by the method, decoct gained medicinal liquid by three times and merge, be equally divided into three parts, patient every day is early, middle and late respectively takes portion; It within 10 days, is a course for the treatment of.
(3) the standard of curative effect evaluation:
Cure: body constitution strengthens, with it energetically, nervous, cardiopalmus, gas tight, tachycardia, numb limbs and tense tendons, myocardial ischemia, sleep and not good enoughly wait transference cure, disease is fully recovered.
Take a turn for the better: body constitution strengthens, with it energetically, nervous, cardiopalmus, gas tight, tachycardia, numb limbs and tense tendons, myocardial ischemia, the symptom such as to sleep not good enough is alleviated to some extent.
Do not heal: disease has no improvement.
(4) therapeutic outcome: it is routine that the present invention treats arteriosclerotic 70 altogether, through the treatment of 2-4 the course for the treatment of, cures 49 examples, accounts for 70%, and take a turn for the better 14 examples, accounts for 20%, and do not heal 7 examples, and account for 10%, effective percentage is 90%, has no any side effect; Cure in 49 examples, 2 courses for the treatment of cure 7 examples, and 3 courses for the treatment of cure 15 examples, and 4 courses for the treatment of cure 27 examples.
(5) model case:
1, Wu so-and-so, man, 55 years old, patient's hand tremor, hands acroanesthesia, easily tired, hypomnesis, be diagnosed as arteriosclerosis; Take Chinese medicine preparation of the present invention to take a turn for the better 1 course for the treatment of, cure after 3 courses for the treatment of, follow up a case by regular visits to and do not recur for 1 year.
2, Deng, man, 63 years old, patient was dizzy, dizzy, poor memory, and thinking obviously descends degradation, is diagnosed as arteriosclerosis; Take Chinese medicine preparation of the present invention to take a turn for the better 1 course for the treatment of, cure after 2 courses for the treatment of, follow up a case by regular visits to and do not recur for 2 years.
3, fourth, female, 67 years old, patient's both feet pain, difficulty in walking, can only lie up at ordinary times, be diagnosed as arteriosclerosis; Take Chinese medicine preparation of the present invention to take a turn for the better 1 course for the treatment of, cure after 4 courses for the treatment of, follow up a case by regular visits to and do not recur for 2 years.
Detailed description of the invention
Embodiment 1:
One treats arteriosclerotic Chinese medicine preparation, is made up of the crude drug of following weight portion: 19 parts, Rhizoma Gastrodiae, Radix Polygoni Multiflori 19 parts, Radix Salviae Miltiorrhizae 19 parts, 11 parts, Folium Bambusae, the Radix Astragali 11 parts, 11 parts, Herba Ephedrae, Semen Cuscutae 8 parts, Radix Ginseng 8 parts, Cortex Lycii 8 parts, Herba speranskiae tuberculatae 8 parts, Rhizoma Et Radix Notopterygii 8 parts, 8 parts, Radix Glycyrrhizae, 4 parts, Poria, Fructus Ligustri Lucidi 4 parts, Carapax Et Plastrum Testudinis 4 parts, Herba Menthae 4 parts, Ramulus Cinnamomi 4 parts, Pheretima 4 parts, Fructus Liquidambaris 4 parts, Radix Achyranthis Bidentatae 4 parts.
The preparation method of the arteriosclerotic Chinese medicine preparation of described treatment, takes each crude drug according to described parts by weight, packs after each crude drug mixing taken, sterilization.
Embodiment 2:
One treats arteriosclerotic Chinese medicine preparation, is made up of the crude drug of following weight portion: 20 parts, Rhizoma Gastrodiae, Radix Polygoni Multiflori 20 parts, Radix Salviae Miltiorrhizae 20 parts, 12 parts, Folium Bambusae, the Radix Astragali 12 parts, 12 parts, Herba Ephedrae, Semen Cuscutae 9 parts, Radix Ginseng 9 parts, Cortex Lycii 9 parts, Herba speranskiae tuberculatae 9 parts, Rhizoma Et Radix Notopterygii 9 parts, 9 parts, Radix Glycyrrhizae, 5 parts, Poria, Fructus Ligustri Lucidi 5 parts, Carapax Et Plastrum Testudinis 5 parts, Herba Menthae 5 parts, Ramulus Cinnamomi 5 parts, Pheretima 5 parts, Fructus Liquidambaris 5 parts, Radix Achyranthis Bidentatae 5 parts.
The preparation method of the arteriosclerotic Chinese medicine preparation of described treatment, takes each crude drug according to described parts by weight, packs after each crude drug mixing taken, sterilization.
Embodiment 3:
One treats arteriosclerotic Chinese medicine preparation, is made up of the crude drug of following weight portion: 21 parts, Rhizoma Gastrodiae, Radix Polygoni Multiflori 21 parts, Radix Salviae Miltiorrhizae 21 parts, 13 parts, Folium Bambusae, the Radix Astragali 13 parts, 13 parts, Herba Ephedrae, Semen Cuscutae 10 parts, Radix Ginseng 10 parts, Cortex Lycii 10 parts, Herba speranskiae tuberculatae 10 parts, Rhizoma Et Radix Notopterygii 10 parts, 10 parts, Radix Glycyrrhizae, 6 parts, Poria, Fructus Ligustri Lucidi 6 parts, Carapax Et Plastrum Testudinis 6 parts, Herba Menthae 6 parts, Ramulus Cinnamomi 6 parts, Pheretima 6 parts, Fructus Liquidambaris 6 parts, Radix Achyranthis Bidentatae 6 parts.
The preparation method of the arteriosclerotic Chinese medicine preparation of described treatment, takes each crude drug according to described parts by weight, packs after each crude drug mixing taken, sterilization.
Claims (3)
1. treat an arteriosclerotic Chinese medicine preparation, it is characterized in that: be made up of the crude drug of following weight portion: Rhizoma Gastrodiae 19-21 part, Radix Polygoni Multiflori 19-21 part, Radix Salviae Miltiorrhizae 19-21 part, Folium Bambusae 11-13 part, Radix Astragali 11-13 part, Herba Ephedrae 11-13 part, Semen Cuscutae 8-10 part, Radix Ginseng 8-10 part, Cortex Lycii 8-10 part, Herba speranskiae tuberculatae 8-10 part, Rhizoma Et Radix Notopterygii 8-10 part, Radix Glycyrrhizae 8-10 part, Poria 4-6 part, Fructus Ligustri Lucidi 4-6 part, Carapax Et Plastrum Testudinis 4-6 part, Herba Menthae 4-6 part, Ramulus Cinnamomi 4-6 part, Pheretima 4-6 part, Fructus Liquidambaris 4-6 part, Radix Achyranthis Bidentatae 4-6 part.
2. the arteriosclerotic Chinese medicine preparation for the treatment of according to claim 1, is characterized in that: be made up of the crude drug of following weight portion: 20 parts, Rhizoma Gastrodiae, Radix Polygoni Multiflori 20 parts, Radix Salviae Miltiorrhizae 20 parts, 12 parts, Folium Bambusae, the Radix Astragali 12 parts, 12 parts, Herba Ephedrae, Semen Cuscutae 9 parts, Radix Ginseng 9 parts, Cortex Lycii 9 parts, Herba speranskiae tuberculatae 9 parts, Rhizoma Et Radix Notopterygii 9 parts, 9 parts, Radix Glycyrrhizae, 5 parts, Poria, Fructus Ligustri Lucidi 5 parts, Carapax Et Plastrum Testudinis 5 parts, Herba Menthae 5 parts, Ramulus Cinnamomi 5 parts, Pheretima 5 parts, Fructus Liquidambaris 5 parts, Radix Achyranthis Bidentatae 5 parts.
3. the preparation method of the arteriosclerotic Chinese medicine preparation for the treatment of according to claim 1 and 2, is characterized in that: take each crude drug according to described parts by weight, packs after each crude drug mixing taken, sterilization.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510455175.6A CN104940712A (en) | 2015-07-30 | 2015-07-30 | Traditional Chinese medicine preparation for treating arteriosclerosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510455175.6A CN104940712A (en) | 2015-07-30 | 2015-07-30 | Traditional Chinese medicine preparation for treating arteriosclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104940712A true CN104940712A (en) | 2015-09-30 |
Family
ID=54156135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510455175.6A Pending CN104940712A (en) | 2015-07-30 | 2015-07-30 | Traditional Chinese medicine preparation for treating arteriosclerosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104940712A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435118A (en) * | 2015-12-29 | 2016-03-30 | 青岛昌安达药业有限公司 | Traditional Chinese medicine for treating arteriosclerosis |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101121002A (en) * | 2006-08-10 | 2008-02-13 | 张秀云 | Chinese preparatory medicine for treating high blood pressure and cardiovascular and cerebrovascular diseases |
| CN101461900A (en) * | 2007-12-17 | 2009-06-24 | 吴伶 | Pure medicinal formulation for treating arteriosclerosis |
| CN103919996A (en) * | 2014-04-21 | 2014-07-16 | 柳少逸 | Traditional Chinese medicine for treating arteriosclerosis |
-
2015
- 2015-07-30 CN CN201510455175.6A patent/CN104940712A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101121002A (en) * | 2006-08-10 | 2008-02-13 | 张秀云 | Chinese preparatory medicine for treating high blood pressure and cardiovascular and cerebrovascular diseases |
| CN101461900A (en) * | 2007-12-17 | 2009-06-24 | 吴伶 | Pure medicinal formulation for treating arteriosclerosis |
| CN103919996A (en) * | 2014-04-21 | 2014-07-16 | 柳少逸 | Traditional Chinese medicine for treating arteriosclerosis |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435118A (en) * | 2015-12-29 | 2016-03-30 | 青岛昌安达药业有限公司 | Traditional Chinese medicine for treating arteriosclerosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1985965A (en) | Medicine for treating coronary heart disease and cerebral thrombus and its preparing method | |
| CN104161868A (en) | Drug for treating rheumatoid arthritis | |
| CN103041336B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN105012735B (en) | One kind fills blood anticancer traditional Chinese medicinal composition | |
| CN103356969A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN103349759B (en) | Traditional Chinese medicine composition for treating ovarian cyst | |
| CN103356925B (en) | Traditional Chinese medicine composition for treating sperm non-liquified symptom | |
| CN103251916B (en) | Chinese herb preparation for treating peripheral neuritis | |
| CN102631450B (en) | Traditional Chinese medicine (TCM) decoction for treating wind-cold type common cold | |
| CN102512645B (en) | Traditional Chinese medicine composition for treating lumbago due to cold dampness | |
| CN104940712A (en) | Traditional Chinese medicine preparation for treating arteriosclerosis | |
| CN102641471A (en) | Traditional Chinese medicine for treating cholelithiasis | |
| CN102940816B (en) | Traditional Chinese medicine for treating gout | |
| CN103099879B (en) | Traditional Chinese medicine (TCM) preparation for treating fifth-watch diarrhea | |
| CN104645207A (en) | Traditional Chinese medicine composition for treating angina | |
| CN103721003A (en) | Traditional Chinese medicine preparation for treating kidney essence deficiency type pediatric hydrocephalus | |
| CN102380017A (en) | Medicament for treating diabetes and preparation method of medicament | |
| CN104013718A (en) | Field thistle decoction traditional Chinese medicine preparation | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN102940833B (en) | Traditional Chinese medicine composition for treating coronary heart disease and preparation method thereof | |
| CN102716279B (en) | Salvia miltiorrhiza traditional Chinese herbal preparation for treating hypochondriac pain and preparation method thereof | |
| CN101732690A (en) | Formula for treating phlebothrombosis and preparation method thereof | |
| CN106110215A (en) | A kind of medicine treating varicose veins of the lower extremity | |
| CN105770815A (en) | Folium artemisiae argyi-containing traditional Chinese medicine composition for treating postpartum collapse and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150930 |